Hochschulschrift
Expressionsmuster des Apoptoseproteins Programmed Cell Death Protein 4 (Pdcd4) in urologischen Tumoren
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
21 cm
- Extent
-
102 S.
- Language
-
Deutsch
- Notes
-
Ill., graph. Darst.
Bonn, Univ., Diss., 2014 (Nicht für den Austausch)
- Classification
-
Medizin, Gesundheit
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:32 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Expressionsmuster des Apoptoseproteins Programmed Cell Death Protein 4 (Pdcd4) in urologischen Tumoren
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Energy requirement in programmed cell death
Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Regulation of programmed erythrocyte death by xenobiotics
Regulation of programmed cell death by Brd4
Hairy cell leukemia expresses programmed death-1
Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes
Zur lymphographischen Diagnostik bei urologischen Tumoren
Histonmethylierung als Prognosemarker bei urologischen Tumoren
Expressionsmuster des Apoptoseproteins Programmed Cell Death Protein 4 (Pdcd4) in urologischen Tumoren
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Energy requirement in programmed cell death
Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Regulation of programmed erythrocyte death by xenobiotics
Regulation of programmed cell death by Brd4
Hairy cell leukemia expresses programmed death-1
Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes
Zur lymphographischen Diagnostik bei urologischen Tumoren
Histonmethylierung als Prognosemarker bei urologischen Tumoren
Expressionsmuster des Apoptoseproteins Programmed Cell Death Protein 4 (Pdcd4) in urologischen Tumoren
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Energy requirement in programmed cell death
Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Regulation of programmed erythrocyte death by xenobiotics
Regulation of programmed cell death by Brd4
Hairy cell leukemia expresses programmed death-1
Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes
Zur lymphographischen Diagnostik bei urologischen Tumoren